The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Buyer Name: The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Buyer Address: Gyle Square (NSS Head Office), 1 South Gyle Crescent, Edinburgh, UKM, EH12 9EB
Contact Name: Gordon Dickson
Contact Email: gordon.dickson@nhs.scot
Contact Telephone: +44 1313145522
Buyer Name: Northern Ireland Blood Transfusion Service
Buyer Address: Belfast, UKN06, BT9 7TS
Contact Email: roisin.mcdonald@hscni.net
Buyer Name: Welsh Blood Service
Buyer Address: Pontyclun, UKL, CF72 9WB
Contact Email: rachel.evans41@wales.nhs.uk
The Scottish National Blood Transfusion Service, Northern Ireland Blood Transfusion Service and Welsh Blood Service all require a fully integrated microbiology managed service system for NAT (Nucleic Acid Testing). This includes equipment, maintenance, consumables, spare parts, upgrades, training, clinical education material, remote diagnostics, reporting and supports all to deliver a final result to the Authorityâs information management system. Mandatory assays include the ability to detect HCV RNA, HBV DNA, HIV RNA, HEV RNA, B19V DNA and HAV RNA in plasma/serum samples from blood donors and HCV RNA, HIV RNA, HBV DNA, HEV RNA, B19V DNA and HAV RNA in plasma/ serum samples from tissue and stem cell donors.
Some PCS documents require login and recording interest on the source portal before download links are available.
No linked documents found for this notice.
External Link: https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=OCT541811
Link Title: Nucleic Acid Testing (NAT) Managed Service
Link Description: The Scottish National Blood Transfusion Service, Northern Ireland Blood Transfusion Service and Welsh Blood Service all require a fully integrated microbiology managed service system for NAT (Nucleic Acid Testing). This includes equipment, maintenance, consumables, spare parts, upgrades, training, clinical education material, remote diagnostics, reporting and supports all to deliver a final result to the Authorityâs information management system. Mandatory assays include the ability to detect HCV RNA, HBV DNA, HIV RNA, HEV RNA, B19V DNA and HAV RNA in plasma/serum samples from blood donors and HCV RNA, HIV RNA, HBV DNA, HEV RNA, B19V DNA and HAV RNA in plasma/ serum samples from tissue and stem cell donors.
Lot Description: The Scottish National Blood Transfusion Service, Northern Ireland Blood Transfusion Service and the Welsh Blood Service each require a fully integrated microbiology managed service system for NAT (Nucleic Acid Testing). This includes equipment, maintenance, consumables, spare parts, upgrades, training, clinical education material, remote diagnostics, reporting and supports all to deliver a final result to the Authorityâs information management system. Mandatory assays include the ability to detect HCV RNA, HBV DNA, HIV RNA, HEV RNA, B19V DNA and HAV RNA in plasma/serum samples from blood donors and HCV RNA, HIV RNA, HBV DNA, HEV RNA, B19V DNA and HAV RNA in plasma/ serum samples from tissue and stem cell donors. The Authorities currently have the ability to detect Hepatitis C (HCV) ribonucleic acid (RNA), Human Immunodeficiency virus (HIV) RNA and Hepatitis B (HBV) deoxyribonucleic acid (DNA) in donations from blood, tissue and stem cell donors. Tissue and stem cell donations may only be tested as individual donations for HCV RNA, HBV DNA, HIV RNA. SNBTS test various tissue and stem cell blood samples as singletons but do not carry out any testing on non-heart beating donations. An approximate indication of volumes for this testing is 1500 samples per annum. The Authorities currently have the ability to detect Hepatitis E (HEV)) in donations from blood, tissue and stem cell donors. The successful Bidders system must be capable of detecting HEV RNA. (95% of donations will be tested in pools, 5% as ID NAT). SNBTS currently have the ability to detect B19 DNA and HAV RNA in donations from blood, tissue and stem cell donors. If screening is performed in minipools, B19 testing must ensure that B19 DNA can be detected at a level that will ensure less than 104 IU/mL of B19V DNA in homogenous plasma pools. WNV Testing is currently performed as a discretionary test by SNBTS and WBS and will possibly be introduced during the lifespan of the contract by NIBTS. The routine screening period for WNV RNA commences each year on 1st May and ends 31st December however there is still a requirement to undertake a limited amount of screening in the intervening period. The requirements for WNV RNA testing are reviewed annually. The Authorities uses a combination of Serum, EDTA plasma and EDTA gel collection tubes for all microbiological screening and the successful Bidders system must therefore be validated for both sample types.
Lot 1 Status: complete
Lot 1 Has Options: Yes
Lot 1 Options: The Authority shall be entitled, at its option, to continue this Agreement beyond the Initial Term for three (3) twelve (12) Contract Month periods subject to giving not less than nine (9) Contract Monthsâ notice to the Contractor.
Lot 1 Award Criterion (quality): Technical
Document Title: Nucleic Acid Testing (NAT) Managed Service
Document Description: The Scottish National Blood Transfusion Service, Northern Ireland Blood Transfusion Service and Welsh Blood Service all require a fully integrated microbiology managed service system for NAT (Nucleic Acid Testing). This includes equipment, maintenance, consumables, spare parts, upgrades, training, clinical education material, remote diagnostics, reporting and supports all to deliver a final result to the Authorityâs information management system. Mandatory assays include the ability to detect HCV RNA, HBV DNA, HIV RNA, HEV RNA, B19V DNA and HAV RNA in plasma/serum samples from blood donors and HCV RNA, HIV RNA, HBV DNA, HEV RNA, B19V DNA and HAV RNA in plasma/ serum samples from tissue and stem cell donors.
{
"awards": [
{
"id": "NSS03724",
"relatedLots": [
"1"
],
"suppliers": [
{
"id": "org-109",
"name": "Roche Diagnostics Ltd"
}
]
}
],
"bids": {
"statistics": [
{
"id": "306",
"measure": "bids",
"relatedLot": "1",
"value": 2.0
},
{
"id": "307",
"measure": "smeBids",
"relatedLot": "1",
"value": 0.0
},
{
"id": "308",
"measure": "foreignBidsFromEU",
"relatedLot": "1",
"value": 0.0
},
{
"id": "309",
"measure": "foreignBidsFromNonEU",
"relatedLot": "1",
"value": 2.0
},
{
"id": "310",
"measure": "electronicBids",
"relatedLot": "1",
"value": 2.0
}
]
},
"buyer": {
"id": "org-106",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")"
},
"contracts": [
{
"awardID": "NSS03724",
"dateSigned": "2025-10-17T00:00:00Z",
"id": "NSS03724",
"status": "active",
"value": {
"amount": 7300000.0,
"currency": "GBP"
}
}
],
"date": "2025-10-20T00:00:00Z",
"description": "(SC Ref:808450)",
"id": "rls-29-OCT541811",
"initiationType": "tender",
"language": "EN",
"links": [
{
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000780835",
"rel": "canonical"
}
],
"ocid": "ocds-r6ebe6-0000780835",
"parties": [
{
"address": {
"locality": "Edinburgh",
"postalCode": "EH12 9EB",
"region": "UKM",
"streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent"
},
"contactPoint": {
"email": "gordon.dickson@nhs.scot",
"name": "Gordon Dickson",
"telephone": "+44 1313145522",
"url": "http://"
},
"details": {
"classifications": [
{
"id": "Body governed by public law",
"scheme": "TED_CA_TYPE"
},
{
"description": "Health",
"id": "07",
"scheme": "COFOG"
}
],
"url": "http://www.nss.nhs.scot/browse/procurement-and-logistics"
},
"id": "org-106",
"identifier": {
"legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")"
},
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")",
"roles": [
"buyer"
]
},
{
"address": {
"locality": "Belfast",
"postalCode": "BT9 7TS",
"region": "UKN06"
},
"contactPoint": {
"email": "roisin.mcdonald@hscni.net"
},
"id": "org-107",
"identifier": {
"legalName": "Northern Ireland Blood Transfusion Service"
},
"name": "Northern Ireland Blood Transfusion Service",
"roles": [
"buyer"
]
},
{
"address": {
"locality": "Pontyclun",
"postalCode": "CF72 9WB",
"region": "UKL"
},
"contactPoint": {
"email": "rachel.evans41@wales.nhs.uk"
},
"id": "org-108",
"identifier": {
"legalName": "Welsh Blood Service"
},
"name": "Welsh Blood Service",
"roles": [
"buyer"
]
},
{
"address": {
"locality": "Burgess Hill",
"postalCode": "RH15 9RY",
"region": "UK",
"streetAddress": "Charles Avenue"
},
"contactPoint": {
"telephone": "+44 1444256000"
},
"details": {
"scale": "large",
"url": "http://"
},
"id": "org-109",
"identifier": {
"legalName": "Roche Diagnostics Ltd"
},
"name": "Roche Diagnostics Ltd",
"roles": [
"supplier"
]
},
{
"address": {
"locality": "Edinburgh",
"postalCode": "EH1 1RQ",
"streetAddress": "Parliament House, Parliament Square"
},
"contactPoint": {
"url": "http://"
},
"id": "org-21",
"identifier": {
"legalName": "Court of Session"
},
"name": "Court of Session",
"roles": [
"reviewContactPoint",
"reviewBody"
]
}
],
"relatedProcesses": [
{
"id": "1",
"identifier": "2024/S 000-034339",
"relationship": [
"planning"
],
"scheme": "EU-OJ"
}
],
"tag": [
"award",
"contract"
],
"tender": {
"classification": {
"id": "50421000",
"scheme": "CPV"
},
"coveredBy": [
"GPA"
],
"description": "The Scottish National Blood Transfusion Service, Northern Ireland Blood Transfusion Service and Welsh Blood Service all require a fully integrated microbiology managed service system for NAT (Nucleic Acid Testing). This includes equipment, maintenance, consumables, spare parts, upgrades, training, clinical education material, remote diagnostics, reporting and supports all to deliver a final result to the Authority\u00e2\u0080\u0099s information management system. Mandatory assays include the ability to detect HCV RNA, HBV DNA, HIV RNA, HEV RNA, B19V DNA and HAV RNA in plasma/serum samples from blood donors and HCV RNA, HIV RNA, HBV DNA, HEV RNA, B19V DNA and HAV RNA in plasma/ serum samples from tissue and stem cell donors.",
"documents": [
{
"description": "The Scottish National Blood Transfusion Service, Northern Ireland Blood Transfusion Service and Welsh Blood Service all require a fully integrated microbiology managed service system for NAT (Nucleic Acid Testing). This includes equipment, maintenance, consumables, spare parts, upgrades, training, clinical education material, remote diagnostics, reporting and supports all to deliver a final result to the Authority\u00e2\u0080\u0099s information management system. Mandatory assays include the ability to detect HCV RNA, HBV DNA, HIV RNA, HEV RNA, B19V DNA and HAV RNA in plasma/serum samples from blood donors and HCV RNA, HIV RNA, HBV DNA, HEV RNA, B19V DNA and HAV RNA in plasma/ serum samples from tissue and stem cell donors.",
"documentType": "awardNotice",
"format": "text/html",
"id": "OCT541811",
"title": "Nucleic Acid Testing (NAT) Managed Service",
"url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=OCT541811"
}
],
"id": "NSS003724",
"items": [
{
"additionalClassifications": [
{
"id": "50421000",
"scheme": "CPV"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"id": "1",
"relatedLot": "1"
}
],
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"lots": [
{
"awardCriteria": {
"criteria": [
{
"description": "20",
"name": "Technical",
"type": "quality"
},
{
"description": "80",
"type": "price"
}
]
},
"description": "The Scottish National Blood Transfusion Service, Northern Ireland Blood Transfusion Service and the Welsh Blood Service each require a fully integrated microbiology managed service system for NAT (Nucleic Acid Testing). This includes equipment, maintenance, consumables, spare parts, upgrades, training, clinical education material, remote diagnostics, reporting and supports all to deliver a final result to the Authority\u00e2\u0080\u0099s information management system. Mandatory assays include the ability to detect HCV RNA, HBV DNA, HIV RNA, HEV RNA, B19V DNA and HAV RNA in plasma/serum samples from blood donors and HCV RNA, HIV RNA, HBV DNA, HEV RNA, B19V DNA and HAV RNA in plasma/ serum samples from tissue and stem cell donors.\r\n The Authorities currently have the ability to detect Hepatitis C (HCV) ribonucleic acid (RNA), Human Immunodeficiency virus (HIV) RNA and Hepatitis B (HBV) deoxyribonucleic acid (DNA) in donations from blood, tissue and stem cell donors.\r\n Tissue and stem cell donations may only be tested as individual donations for HCV RNA, HBV DNA, HIV RNA. SNBTS test various tissue and stem cell blood samples as singletons but do not carry out any testing on non-heart beating donations. An approximate indication of volumes for this testing is 1500 samples per annum.\r\n The Authorities currently have the ability to detect Hepatitis E (HEV)) in donations from blood, tissue and stem cell donors. The successful Bidders system must be capable of detecting HEV RNA. (95% of donations will be tested in pools, 5% as ID NAT).\r\n SNBTS currently have the ability to detect B19 DNA and HAV RNA in donations from blood, tissue and stem cell donors. If screening is performed in minipools, B19 testing must ensure that B19 DNA can be detected at a level that will ensure less than 104 IU/mL of B19V DNA in homogenous plasma pools.\r\n WNV Testing is currently performed as a discretionary test by SNBTS and WBS and will possibly be introduced during the lifespan of the contract by NIBTS.\r\n The routine screening period for WNV RNA commences each year on 1st May and ends 31st December however there is still a requirement to undertake a limited amount of screening in the intervening period. The requirements for WNV RNA testing are reviewed annually.\r\n The Authorities uses a combination of Serum, EDTA plasma and EDTA gel collection tubes for all microbiological screening and the successful Bidders system must therefore be validated for both sample types.",
"hasOptions": true,
"id": "1",
"options": {
"description": "The Authority shall be entitled, at its option, to continue this Agreement beyond the Initial Term for three (3) twelve (12) Contract Month periods subject to giving not less than nine (9) Contract Months\u00e2\u0080\u0099 notice to the Contractor."
},
"status": "complete"
}
],
"mainProcurementCategory": "services",
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"status": "complete",
"title": "Nucleic Acid Testing (NAT) Managed Service"
}
}